Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

New antipsychotic drugs from HMR

April 5, 1996

Meiji claims improved antipsychotic agents

April 5, 1996

Pherin develops vomeropherins for anxiety

April 5, 1996

Lilly's tachykinin antagonists for chronic pain

April 5, 1996

Solvay acquires betahistine rights

March 15, 1996

Alpha2-adrenoceptor antagonists with neuroprotective effects

March 15, 1996

Astra antioxidants for hypoxia

March 15, 1996

Pierre Fabre reports antioxidants with neurologic activity

March 15, 1996

Antioxidants to treat Alzheimer's disease?

March 15, 1996

Cyclahexadiene derivatives reported by Bayer for AD

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...